External Fixators as an Adjunct to Wound Healing

Autor: Mark W. Clemens, Melanie M. Hall, Christopher E. Attinger, Pranay M. Parikh

Publikováno v: Foot and Ankle Clinics. 13:145-156

Complex foot and ankle wounds present multiple challenges for the reconstructive surgeon. Soft tissue deficits must be closed to protect underlying structures from infection and to provide a stable environment for healing. Surgical options commonly u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8944a6b10a205d49ee2c751e391c2a6
https://doi.org/10.1016/j.fcl.2007.12.001

Use of External Fixation for Soft Tissue Reconstruction of Foot and Ankle Wounds in the Non-Compliant Patient

Autor: Pranay M. Parikh, Christopher E. Attinger, Melanie M. Hall

Publikováno v: Journal of Reconstructive Microsurgery. 22

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::05cd6fd96937d7e33be7f15941f30bd8
https://doi.org/10.1055/s-2006-958670

Depletion of high-content CD14 ⁺ cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing.

Autor: Wang X; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Borquez-Ojeda O; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Stefanski J; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Du F; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Qu J; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chaudhari J; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Thummar K; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhu M; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shen LB; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hall M; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gautam P; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wang Y; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sénéchal B; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sikder D; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Adusumilli PS; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Brentjens RJ; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Curran K; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Geyer MB; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mailankhody S; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., O'Cearbhaill R; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Park JH; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sauter C; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Slovin S; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Smith EL; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rivière I; Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Publikováno v: Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2021 Jul 16; Vol. 22, pp. 377-387. Date of Electronic Publication: 2021 Jul 16 (Print Publication: 2021).

Monitoring cerebral tissue oxygen saturation at frontal and parietal regions during carotid artery stenting.

Autor: Meng L; Department of Anesthesia and Perioperative Care, University of California, San Francisco, 500 Parnassus Ave, Box 0648, San Francisco, CA, 94143, USA. meng.lingzhong@gmail.com., Hall M; Department of Anesthesia and Perioperative Care, University of California, San Francisco, 500 Parnassus Ave, Box 0648, San Francisco, CA, 94143, USA., Settecase F; Division of Neuro Interventional Radiology, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA., Higashida RT; Division of Neuro Interventional Radiology, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA., Gelb AW; Department of Anesthesia and Perioperative Care, University of California, San Francisco, 500 Parnassus Ave, Box 0648, San Francisco, CA, 94143, USA.

Publikováno v: Journal of anesthesia [J Anesth] 2016 Apr; Vol. 30 (2), pp. 340-4. Date of Electronic Publication: 2015 Dec 16.

The INCENTIVE protocol: an evaluation of the organisation and delivery of NHS dental healthcare to patients-innovation in the commissioning of primary dental care service delivery and organisation in the UK.

Autor: Pavitt SH; Centre for Health Services Research, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Baxter PD; Division of Biostatistics, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Brunton PA; School of Dentistry, University of Leeds, Leeds, UK., Douglas G; School of Dentistry, University of Leeds, Leeds, UK., Edlin R; School of Population Health, University of Auckland, Auckland, New Zealand., Gibson BJ; School of Clinical Dentistry, Sheffield, UK., Godson J; School of Dentistry, University of Leeds, Leeds, UK Public Health England, Regional Office, Leeds, UK., Hall M; School of Clinical Dentistry, Sheffield, UK., Porritt J; Department of Psychology, Sociology & Politics Collegiate Campus Sheffield Hallam University, Sheffield, UK., Robinson PG; School of Clinical Dentistry, Sheffield, UK., Vinall K; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Hulme C; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.

Publikováno v: BMJ open [BMJ Open] 2014 Sep 17; Vol. 4 (9), pp. e005931. Date of Electronic Publication: 2014 Sep 17.